Have We Reached the Medtech ‘Tipping Point’?
Changes in the medtech industry have resulted in new buyer behavior, sales strategies and sales resource requirements. ZS recommends four steps to adapt your sales compensation program to support growth and retain talent in this new environment.
It’s a Whole New Digital World for Life Sciences
It’s no secret that life sciences organizations need to make major changes in team coordination, data acquisition and insight generation. But, what’s the key to success? Read this ZS and Gartner news briefing to learn how a digital strategy and approach can completely change the future of a life sciences organization.
Pick Up the Pace on Patient Centricity
The goal of every life sciences company is to help patients, but many companies struggle with a patient-centric strategy especially when it comes to drug development. Read this article to learn how a patient-centered approach can alter clinical trials and the four pillars you need to incorporate today.
Always Be Launching
As the commercial viability of cancer drugs increasingly relies on approval in multiple settings, it becomes more important than ever to develop a more “continuous” launch model, write Sarah Hamilton and Dave Cohen.
The Role of Value in Market Access and Pricing Negotiations
In the first chapter—"The Role of Value in Market Access and Pricing Negotiations"—of the recently published book, The Future of Health Economics, Ed Schoonveld describes critical success factors for market access and pricing of prescription drugs.
Big Data: Is It Crunch Time for Pharma?
ZS Managing Principal, Dharmendra Sahay weighs on Pharma’s Big Data evolution with Pharmaceutical Executive. Read this article to learn how companies continue to overcome adoption challenges and find new ways to benefit from Big Data and analytics.
Achieving the Promise of Analytics
ZS and CIO.com recently surveyed healthcare chief information officers and senior-level IT leaders on their analytics opportunities, planned investments and overall analytics strategies. Read this article to learn where companies are still struggling and seven key steps to progress an analytics strategy.
Why Medtech Companies Should Implement Regionalized Sales Models
In today’s dynamic healthcare environment, IDN consolidation and centralized medical device purchasing are creating significant pricing pressure on the medical device industry. In fact, on average, prices for costly medical devices have been declining recently, according to the Emergency Care Research Institute. Medtech business leaders, therefore, have to work to find ways to evolve and grow earnings in this highly competitive and challenging environment.
2017 Value Watch List in US Oncology Market
As part of the ZS Oncology Value Watchdog Initiative, we have identified priority areas for manufacturers to consider as some of the most influential drivers of value-driven cancer care in the US in 2017.
“Value” within healthcare is a complex, abstract concept that can take on many forms. The Healthcare Leadership Council (HLC), a coalition of chief executives and other thought leaders across the healthcare industry—including ZS—has been building consensus on the best ways to deliver value through its National Dialogue for Healthcare Innovation initiative (NDHI).
Ready for an Agile Future
A top-20 pharmaceutical company partnered with ZS to reduce cycle times by 40%, costs by 20%, and to solve a field reporting problem with a mobile, one-stop-shop solution that gives the field more time to sell.
The Digital Enterprise in Action
Amgen’s awardwinning data lake revolutionized the company’s global operations by driving bottom-line savings and enabling new data-driven insights—and, as a bonus, it offered the same potential to the entire company.
Displaying 1 - 15 of 473